| 効果 | なし |
| 試験方法 | メタ分析法 |
| 試験期間 | 不明 |
| 被験者数 | 151 |
| 性別 | 不明 |
この研究の注釈：
Authors noted that further research is required on this topic as ‘important limitations were noted’.
Authors noted that further research is required on this topic as ‘important limitations were noted’.
4 Trials assessed.
Creatine was still regarded as safe and well-tolerated; just ineffective.
Creatine Supplementation Improves Muscle Strength In Patients With Congestive Heart Failure
| 効果 | なし |
| 試験方法 | 二重盲検法 |
| 試験期間 | 1-6 ヶ月 |
| 被験者数 | 20 |
| 性別 | 男女 |
| 年齢 | 45-64, 65+ |
| 体型 | 肥満 |
この研究の注釈：
Patients with Congestive Heart Failure (CHF) had increases in body weight and strength when using creatine monohydrate at 20g daily (no loading or maintenance, but a continual dosage for 6 weeks) but no improvement in cardiovascular exercise capacity.
Creatine Supplementation Improves Muscle Strength In Patients With Congestive Heart Failure
| 効果 | 増加 |
| 試験方法 | 二重盲検法 |
| 試験期間 | 1-6 ヶ月 |
| 被験者数 | 20 |
| 性別 | 男女 |
| 年齢 | 45-64, 65+ |
| 体型 | 肥満 |
この研究の注釈：
Patients with Congestive Heart Failure (CHF) had increases in body weight and strength when using creatine monohydrate at 20g daily (no loading or maintenance, but a continual dosage for 6 weeks) but no improvement in cardiovascular exercise capacity.